SCHEMBL9212334

SCHEMBL9212334

C[CH]OC(=O)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
HPGD P15428 3/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
GAA P10253 1/20 0.45
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 2/20 0.43
CYP1A2 P05177 1/20 0.43
ALOX12 P18054 1/20 0.43
CYP2C19 P33261 1/20 0.43
SRD5A2 P31213 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1377357 0.81 CES2 (0.50) ALDH1A1CES2CES1SMN1; SMN2NPC1
SCHEMBL28748274 0.81 CA1 (0.59) ALDH1A1SMN1; SMN2NPC1RAB9AALOX15
SCHEMBL2721321 0.81 TDP1 (0.59) ALDH1A1CES2CES1SMN1; SMN2NPC1
SCHEMBL25289477 0.79 LMNA (0.55) ALDH1A1NPC1RAB9ATSHRGAA
SCHEMBL2538499 0.79 CES2 (0.48) ALDH1A1CES2CES1SMN1; SMN2NPC1
SCHEMBL8743220 0.79 CES2 (0.48) ALDH1A1CES2CES1SMN1; SMN2NPC1
SCHEMBL7868516 0.79 RAB9A (0.49) CES2CES1SMN1; SMN2NPC1RAB9A
SCHEMBL72654 0.78 TSHR (0.58) ALDH1A1CES2CES1SMN1; SMN2L3MBTL1
SCHEMBL8742868 0.78 CA1 (0.64) CES2CES1SMN1; SMN2NPC1CA1
SCHEMBL6649179 0.77 TNF (0.39) ALDH1A1CES2CES1L3MBTL1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0508549-B1 New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia SANKYO CO (JP) 1995-04-26 EP disclosed
EP-0347252-B1 METHOD OF TREATING CACHEXIA AND CERTAIN NEW COMPOUNDS FOR USE IN THIS METHOD SANKYO COMPANY LIMITED (JP) 1993-05-05 EP disclosed
EP-0508549-A2 New triazolopyrimidine and pyrazolopyrimidine derivatives useful for treating cachexia SANKYO COMPANY LIMITED (JP) 1992-10-14 EP disclosed
US-5086057-A METHOD OF TREATING CACHEXIA AND CERTAIN NEW COMPOUNDS FOR USE IN THIS METHOD SANKYO COMPANY LIMITED (JP) 1992-02-04 US disclosed
US-5055479-A For enhancing activity of lipoprotein lipase enzymes SANKYO COMPANY, LIMITED (JP) 1991-10-08 US disclosed
EP-0347252-A2 Method of treating cachexia and certain new compounds for use in this method SANKYO COMPANY LIMITED (JP) 1989-12-20 EP disclosed
US-4241208-A STABILIZERS OF SYNTHETIC POLYMERS AGAINST HEAT AND LIGHT SANKYO COMPANY LIMITED (JP) 1980-12-23 US disclosed
US-4066615-A PHOTOSTABILITY, THERMAL STABILITY SANKYO COMPANY LIMITED (JA) 1978-01-03 US disclosed
US-3941744-A SYNTHETIC RESIN SANKYO COMPANY LIMITED (JA) 1976-03-02 US disclosed